Petr Mlejnek (P Mlejnek)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Chronic Myeloid Leukemia

Oxidative Stress

Top Venues

Journal of cellular biochemistry

Antioxidants (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Petr Mlejnek
What Is the Significance of Lysosomal-Mediated Resistance to Imatinib? Cells 12 (5) (2023)
Petr Mlejnek
What Is the Significance of Lysosomal-Mediated Resistance to Imatinib? Cells 12 (5) (2023)
Petr Mlejnek
What Is the Significance of Lysosomal-Mediated Resistance to Imatinib? Cells 12 (5) (2023)
Petr Mlejnek
Direct Interaction between N -Acetylcysteine and Cytotoxic Electrophile-An Overlooked In Vitro Mechanism of Protection. Antioxidants (Basel, Switzerland) 11 (8) (2022)
N Pastvova, J Havlasek, P Dolezel, K Kikalova, H Studentova, A Zemankova, B Melichar, Petr Mlejnek
Changes in expression of lysosomal membrane proteins in leucocytes of cancer patients treated with tyrosine kinase inhibitors. Cancer chemotherapy and pharmacology 88 (1) (2021)
Petr Mlejnek, Petr Dolezel, Eva Kriegova, Nikola Pastvova
N-acetylcysteine Can Induce Massive Oxidative Stress, Resulting in Cell Death with Apoptotic Features in Human Leukemia Cells. International journal of molecular sciences 22 (23) (2021)
Nikola Pastvova, Petr Dolezel, Petr Mlejnek
Heat Shock Protein Inhibitor 17-Allyamino-17-Demethoxygeldanamycin, a Potent Inductor of Apoptosis in Human Glioma Tumor Cell Lines, Is a Weak Substrate for ABCB1 and ABCG2 Transporters. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Petr Mlejnek, Petr Kosztyu, Petr Dolezel, Yasuhisa Kimura, Katerina Cizkova, Eliska Ruzickova
Estimation of ABCB1 concentration in plasma membrane. Journal of cellular biochemistry 120 (10) (2019)